Startups
Eyenuk
Los Angeles, California, United States
Eyenuk develops retinal-image analysis software that brings AI screening and eye-care coordination into primary care, diabetes clinics and ophthalmic practices. Its EyeArt system analyzes photographs of the retina to autonomously detect more-than-mild and vision-threatening diabetic retinopathy and return a diagnostic report without a specialist reading every exam. EyeArt has FDA 510(k) clearance for diabetic-retinopathy detection in the United States; the company also reports EU MDR Class IIb certification for detecting diabetic retinopathy, age-related macular degeneration and glaucomatous optic-nerve damage. Its EyeScreen workflow supports expert human review of inconclusive images and non-DR findings, prioritized referrals and integration with electronic health records. A longitudinal monitoring workspace lets clinicians compare retinal findings and follow disease progression. Eyenuk also researches retinal biomarkers for systemic cardiovascular and neurological health; these research ambitions do not establish regulatory clearance for diagnosing Alzheimer’s disease or other neurological conditions. Founded in 2010, the company operates from the Los Angeles area and publishes a San Francisco correspondence address.
Founded 2010